Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
back to News Search
     
Strength, Timing, and Proper Neuronal Development

1 February 2009. Like the flying trapeze, brain development requires a delicate balance of strength and timing. If either is off, connections fail and the whole act can falter. Two recent Nature papers emphasize as much, and one of them, surprisingly, suggests that getting disrupted development back into the swing of things may be easier than it seems. Both papers may have implications for schizophrenia research.

In the 11 January Nature Genetics online, researchers led by Orly Reiner, The Weizmann Institute of Science, Rehovot, Israel, and James Lupinski, Baylor College of Medicine, Houston, Texas, report that overexpression of the gene LIS1 causes brain development problems in both mice and humans. Mutations in LIS1 are known to cause lissencephaly, a developmental brain disorder, but this is the first time researchers have shown that having too much of the lissencephaly 1 protein (the product of the LIS1 gene) can be just as problematic as having too little. LIS1 is of particular interest to schizophrenia researchers because it is a DISC1 binding partner (see SRF related news story). DISC1 mutations have been linked to aberrant neuronal migration and neuronal development (see Kamiya et al., 2005 and SRF related news story), and the DISC1 gene is a strong schizophrenia risk gene candidate (see SRF related news story). The second paper also has a lissencephaly connection. Joseph LoTurco and colleagues at the University of Connecticut in Storrs report that restoring expression of the doublecortin gene (DCX) after birth helps rescue failed neuronal development that occurs in the absence of Dcx. In fact, loss of DCX also causes lissencephaly and leads to epileptic seizures in animals. The researchers show that turning on DCX after birth reduces seizure activity and restores proper neuronal migration. The work, described in the 21 December Nature Medicine online, hints that it may be possible to treat neuronal migration disorders by rebooting neuronal development, even after birth.

Too much of a good thing
Reiner and colleagues made the connection between LIS1 overexpression and development when they identified seven unrelated individuals with duplications of a small region of chromosome 17 (17p13.3) that houses the LIS1 gene. Joint first authors Weimin Bi, Tamar Sapir, Oleg Shchelochkov, and colleagues found that four of those patients carried a duplication of YWHAE, a gene that encodes the protein 14-3-3ε, and that has been associated with schizophrenia (see comment by A. Kamiya). Two patients had a duplication of PAFAH1B1, the gene encoding LIS1, while one patient had a duplication that spanned both genes. Patients carrying the additional PAFAH1B1 gene had more severe abnormalities, including moderate to severely delayed development, reduced cerebral volume, malformation of the corpus callosum, and significant atrophy of the cerebellum.

To test if the extra gene copies are related to the patients’ disabilities, the researchers took two approaches. They first explored whether the extra genes were functional, and found increased expression of LIS1and 14-3-3ε in patients with an extra PAFAH1B1 and YWHAE gene, respectively. They also tested the effect of increasing the copy number in mice. Animals with an extra LIS1 gene also showed developmental problems, with a smaller and anatomically more disorganized brain. These animals had an increase in the number of mitotic cells in the ventricular zone and also an increased number of cells undergoing apoptosis, or programmed cell death. Cells had also lost their polarity, or ability to navigate, a major detriment to proper cell migration. Using time lapse microscopy, the authors found that cell motility was significantly reduced in mice with an extra LIS1 copy. In all, the findings indicate that overexpression of LIS1 causes major setbacks for proper brain development.

Double trouble
Doublecortin may also be essential for cell polarity (see Cardoso et al., 2003), which could explain why it is needed for proper neuronal migration and development. Mutations in DCX lead to a condition called, not surprisingly, double cortex, in which an extra band of gray matter, comprising abnormally migrated neurons, appears between the ventricles and the cortex proper. In humans this causes mild to moderate mental retardation. Pockets of wayward neurons are also found in other human conditions, such as some severe forms of epilepsy that are usually not responsive to pharmacologic intervention, and in a variety of animal models. Many of these conditions, referred to as subcortical band heterotopias in reference to the misplaced neurons, are accompanied by seizures, suggesting that the wayward neuronal migration alters connectivity in such a way that neural networks become hyperexcitable.

LoTurco and colleagues tested whether reactivating cell migration might mitigate disabilities, including seizure, that accompany subcortical band heterotopia (SBH). First author Jean-Bernard Manent and colleagues knocked down Dcx expression in utero in rat pups using RNAi, then conditionally re-expressed Dcx at birth using a construct that lacks the 3’UTR targeted by the RNAi knockdown. The result was pups that had no Dcx between embryonic day 14 and birth, but then had Dcx re-expressed.

The RNAi approach led to pronounced SBH at birth. Neuronal malformations were significantly reduced, however, when Dcx re-expression was induced at birth with neurons actually migrating into the upper layers of the cortex, as in control pups, by P20. Those neurons that migrated to the correct position after postnatal induction of Dcx also appeared morphologically normal, expressing upper cortical layer markers and having a normal looking dendritic tree. The reduction in SBH was accompanied by a dramatic improvement in susceptibility to seizure. At P30, Dcx-re-expressing rats showed the same sensitivity to seizure induction as normal rats of the same age.

The study indicates that it may be possible to correct diseases caused by neuronal migration deficits even after birth. “To our knowledge, this is the first study to demonstrate that a molecular intervention can reduce the size and functional effects of a pre-existing disruption in neuronal migration,” write the authors. Their strategy, electroporating DNA constructs into the brain in utero, could not be used in humans, however, but the authors suggest possible alternative approaches, including viral transduction of cells with appropriate DNAs, and/or pharmacological intervention that boosts Dcx signaling pathways. Whether either strategy would work in humans is not clear, and it will probably be a long time before either would even be considered. There is also another drawback—the intervention would most likely have to be given before birth because the authors found that if they waited until P5 the strategy was less successful, while at P10 (the equivalent of full-term infants in humans) it failed to mitigate SBH at all. Nevertheless, the finding opens up the possibility that developmental problems stemming from abnormal neural migration could be treated after the fact. It is not clear whether this strategy could ever apply to conditions that emerge in adolescence, such as schizophrenia, which may, at least in part, have a neurodevelopmental etiology. “In general, our study raises the possibility that, in some contexts, neuronal migration is a form of neuronal plasticity that may be engaged to induce neural repair,” write the authors.—Tom Fagan.

References:
Bi W, Sapir T, Shchelochkov OA, Zhang F, Withers MA, Hunter JV, Levy T, Shinder V, Peiffer DA, Gunderson KL, Nezarati MM, Shotts VA, Amato SS, Savage SK, Harris DJ, Day-Salvatore D-L, Horner M, Lu X-Y, Sahoo T, Yanagawa Y, Beaudet AL, Cheung SW, Martinez S, Lupski JR, Reiner R. Increased LIS1 expression affects human and mouse brain development. Nature Genetics advanced online publication. 2009 January 11. Abstract

Manent J-B, Wang Y, Chang YJ, Paramasivam M, LoTurco JJ. Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder. Nature Medicine advanced online publication. 2008, December 21. Abstract

 
Comments on Related News
Related News: Messing with DISC1 Protein Disturbs Development, and More

Comment by:  Anil Malhotra, SRF Advisor
Submitted 21 November 2005 Posted 21 November 2005

The relationship between DISC1 and neuropsychiatric disorders, including schizophrenia, schizoaffective disorder, and bipolar disorder, has now been observed in several studies. Moreover, a number of studies have demonstrated that DISC1 appears to impact neurocognitive function. Nevertheless, the molecular mechanisms by which DISC1 could contribute to impaired CNS function are unclear, and these two papers shed light on this critical issue.

Millar et al. (2005) have followed the same strategy that they so successfully utilized in their initial DISC1 studies, identifying a translocation that associated with a psychotic illness. In contrast to DISC1, in which a pedigree was identified with a number of translocation carriers, this manuscript is based upon the identification of a single translocation carrier, who appears to manifest classic signs of schizophrenia, without evidence of mood dysregulation. Two genes are disrupted by this translocation: cadherin 8 and phosphodiesterase 4B (PDE4B). The...  Read more


View all comments by Anil Malhotra

Related News: Messing with DISC1 Protein Disturbs Development, and More

Comment by:  Angus Nairn
Submitted 29 December 2005 Posted 31 December 2005
  I recommend the Primary Papers

This study describes an interesting genetic link between PDE4B (phosphodiesterase 4B) and schizophrenia that may be related to a physical interaction with DISC1 (disrupted in schizophrenia 1), another gene associated with the psychiatric disorder. The study is highly suggestive of a role for the PDE4B/DISC1 complex in schizophrenia. However, the mechanistic model suggested by the authors whereby DISC1 sequesters PDE4B in an inactive state seems overly speculative, given the results presented in this paper and in prior studies that have examined the regulation of PDE4B by phosphorylation in the absence of DISC1.

View all comments by Angus Nairn


Related News: Messing with DISC1 Protein Disturbs Development, and More

Comment by:  Patricia Estani
Submitted 2 January 2006 Posted 2 January 2006
  I recommend the Primary Papers

Related News: Messing with DISC1 Protein Disturbs Development, and More

Comment by:  Ali Mohammad Foroughmand
Submitted 16 December 2006 Posted 16 December 2006
  I recommend the Primary Papers

Related News: DISC1 Fragment Ties Schizophrenia-like Symptoms to Development in Mice

Comment by:  John Roder
Submitted 30 November 2007 Posted 30 November 2007

Some observations on the new report by Li and colleagues: this work is the first to map subregions of DISC1 and to show that a region that binds Nudel and LIS1 is important in generating schizophrenia-like perturbations in vivo. The authors express DISC1 C-terminus in mice, which interacts with Nudel and LIS1. They showed less native mouse DISC1 associations with Nudel mouse following gene induction. This suggests a dominant-negative mechanism.

No data was shown on native DISC1 levels following induction. Work from the Sawa lab shows that if murine DISC1 levels are reduced in non-engineered mice using RNAi, severe perturbations in development of nervous system are seen (Kamiya et al., 2005); however, behavior was not measured in this study. Severe perturbations would be expected based on the neonatal ventral hippocampal lesion model. In this latter model early brain lesions lead to later impairments in PPI and other behaviors consistent with schizophrenic-like behavior.

They use a promoter only expressed in the forebrain,...  Read more


View all comments by John Roder

Related News: DISC1 Fragment Ties Schizophrenia-like Symptoms to Development in Mice

Comment by:  Akira Sawa, SRF Advisor
Submitted 3 December 2007 Posted 3 December 2007

DISC1 may be a promising entry point to explore important disease pathways for schizophrenia and related mental conditions; thus, animal models that can provide us with insights into the pathways involving DISC1 may be helpful. In this sense, the new animal model reported by Li et al. (Silva and Cannon’s group at UCLA) has great significance in this field.

They made mice expressing a short domain of DISC1 that may block interaction of DISC1 with a set of protein interactors, including NUDEL/NDEL1 and LIS1. This approach, if the domain is much shorter, will be an important methodology in exploring the disease pathways based on protein interactions. Although the manuscript is excellent, and appropriate as the first report, the domain expressed in the transgenic mice can interact with more than 30-40 proteins, and the phenotypes that the authors observed might not be attributable to the disturbance of protein interactions of DISC1 and NUDEL or LIS1.

Now we have at least five different types of animal models for DISC1, all of which have unique advantages and...  Read more


View all comments by Akira Sawa

Related News: DISC1 Fragment Ties Schizophrenia-like Symptoms to Development in Mice

Comment by:  David J. Porteous, SRF Advisor
Submitted 21 December 2007 Posted 22 December 2007

On the DISC1 bus
You wait ages for a bus, then a string of them come one behind the other. First, Koike et al. (2006) reported that the 129 strain of mouse had a small detection of the DISC1 gene and this was associated with a deficit on a learning task. The interpretation of this observation was somewhat complicated by the subsequent recognition that the majority, if not all, major DISC1 isoforms are unaffected by the deletion, but this needs further work (Ishizuka et al., 2007). Then, Clapcote et al. (2007) provided a very detailed characterization of two independent ENU-induced mouse missense mutations of DISC1, showing selective brain shrinkage and marked behavioral abnormalities that in one mutant were schizophrenia-like, the other more akin to mood disorder. Importantly, these phenotypes could be differentially rescued by antipsychotics or antidepressants. The main finger pointed to disruption of the interaction with PDE4...  Read more


View all comments by David J. Porteous
Submit a Comment on this News Article
Make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend the Primary Papers

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
Copyright © 2005- 2013 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright